CDKN2A and cancer: Furthermore, a recent study indicates that the role of p16 in non-OPSCC patients might not be related to HPV positivity, as it is in OPSCC patients,55 in contrast with the results of Bryant et al.,56 which suggest a similar prognostic role for p16 for both types of cancer.